<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ddr21709-tbl-0005" xml:lang="en" content-type="TABLE" orientation="portrait" position="float">
 <label>TABLE 5</label>
 <caption>
  <p>Potential vaccine candidates for SARS‐CoV‐2 that are under different stages of clinical trials</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <thead valign="bottom">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="bottom" rowspan="1" colspan="1">Technology</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Vaccine</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Status of trial</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Sponsor/collaborators</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">NCT number</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td rowspan="2" align="left" valign="top" colspan="1">D NA‐based vaccine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">INO‐4800</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Inovio Pharmaceuticals</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04336410</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">bacTRL‐Spike</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Symvivo Corporation, University of British Columbia, Dalhousie University</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04334980</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" valign="top" colspan="1">Inactivated virus</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CoronaVac (SARS‐CoV‐2 inactivated vaccine)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1/2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Sinovac Biotech Co.</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04352608, NCT04383574</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">V‐SARS</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1/2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Immunitor LLC</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04380532</td>
   </tr>
   <tr>
    <td rowspan="3" align="left" valign="top" colspan="1">Modified APC</td>
    <td align="left" valign="top" rowspan="1" colspan="1">LV‐SMENP‐DC</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1/2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Shenzhen Geno‐Immune Medical Institute</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04276896</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">AV‐COVID‐19</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1/2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Aivita Biomedical, Inc.</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04386252</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Covid‐19/aAPC vaccine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Shenzhen Geno‐Immune Medical Institute</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04299724</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" valign="top" colspan="1">Nonreplicating viral vector</td>
    <td align="left" valign="top" rowspan="1" colspan="1">AZD1222 (ChAdOx1 nCoV‐19)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1/2/3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Consortium of the Jenner Institute, Oxford Biomedica, University of Oxford</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04324606, EudraCT 2020–001072‐15, EudraCT 2020–001228‐32</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Ad5‐nCoV</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1/2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CanSino Biologics Inc., Institute of Biotechnology and so on</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04313127, NCT04341389, NCT04398147, ChiCTR2000031781, ChiCTR2000030906</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" valign="top" colspan="1">Protein subunit</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NVX‐CoV2373 (SARS‐CoV‐2 rS)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Novavax</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04368988</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">SCB‐2019</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Clover Biopharmaceuticals</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04405908</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" valign="top" colspan="1">RNA‐based vaccine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">BNT162</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1/2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Biontech RNA Pharmaceuticals GmbH, Pfizer</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04380701, NCT04368728, EudraCT 2020‐001038‐36</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">mRNA‐1273</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Moderna, NIAID</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04283461</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" valign="top" colspan="1">Repurposed vaccine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bacille Calmette‐Guerin (BCG) vaccine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 3/4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">University Medical Center Utrecht, Radboud University and so on</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04328441, NCT04350931, NCT04362124, NCT04379336, NCT04347876, NCT04327206, NCT04369794, NCT04373291, NCT04384549, NCT04348370, NCT04384614, NCT04387409</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Measles‐mumps‐rubella (MMR) vaccine</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Phase 3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Kasr El Aini Hospital</td>
    <td align="left" valign="top" rowspan="1" colspan="1">NCT04357028</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
